Table 4.
Gestation or Age-adjusted Z-score | Among combination ARV-exposed infants N, Mean (SD) | Exposed to combination regimens with TDF | Exposed to combination regimens without TDF | TDF vs non-TDF P-value2 | ||
---|---|---|---|---|---|---|
| ||||||
Unadjusted N, Mean (SD) | Adjusted1 Mean (SE) | Unadjusted N, Mean (SD) | Adjusted1 Mean (SE) | |||
Weight | 585, −0.07 (1.16) | 217, −0.11 (1.20) | −0.09 (0.08) | 368, −0.05 (1.14) | −0.04 (0.06) | 0.62 |
Length | 582, −0.05 (1.09) | 215, −0.17 (1.00) | −0.17 (0.07) | 367, 0.02 (1.14) | −0.03 (0.06) | 0.04 |
HC | 570, 0.34 (1.20) | 209, 0.23 (1.10) | 0.17 (0.08) | 361, 0.41 (1.25) | 0.42 (0.06) | 0.02 |
TDF=tenofovir disoproxil fumarate, HC=head circumference, SD=standard deviation, SE=standard error
The estimates presented above are from separate models for each outcome adjusted for covariates with p<0.10 in multivariate models, including: Weight z-score at 1 year: gestational age and high maternal viral load prior to delivery; Length z-score at 1 year: Latino ethnicity, high maternal viral load prior to delivery, and maternal use of tobacco during pregnancy; HC z-score at 1 year: low income level, low caregiver education level, and maternal use of illicit drugs during pregnancy.
P-value from linear regression model comparing adjusted means for TDF-exposed vs unexposed.